Literature DB >> 25190729

Avoiding the bad and enhancing the good of soy supplements in breast cancer.

V Craig Jordan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25190729      PMCID： PMC5072365          DOI： 10.1093/jnci/dju233

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  25 in total

1.  Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial.

Authors:  Garnet L Anderson; Rowan T Chlebowski; Aaron K Aragaki; Lewis H Kuller; JoAnn E Manson; Margery Gass; Elizabeth Bluhm; Stephanie Connelly; F Allan Hubbell; Dorothy Lane; Lisa Martin; Judith Ockene; Thomas Rohan; Robert Schenken; Jean Wactawski-Wende
Journal:  Lancet Oncol       Date:  2012-03-07       Impact factor: 41.316

Review 2.  Selective estrogen receptor modulation: concept and consequences in cancer.

Authors:  V Craig Jordan
Journal:  Cancer Cell       Date:  2004-03       Impact factor: 31.743

3.  Influence of Synthetic Oestrogens on Advanced Malignant Disease.

Authors:  A Haddow; J M Watkinson; E Paterson; P C Koller
Journal:  Br Med J       Date:  1944-09-23

4.  Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time.

Authors:  Eric A Ariazi; Heather E Cunliffe; Joan S Lewis-Wambi; Michael J Slifker; Amanda L Willis; Pilar Ramos; Coya Tapia; Helen R Kim; Smitha Yerrum; Catherine G N Sharma; Emmanuelle Nicolas; Yoganand Balagurunathan; Eric A Ross; V Craig Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-19       Impact factor: 11.205

5.  Defining the conformation of the estrogen receptor complex that controls estrogen-induced apoptosis in breast cancer.

Authors:  Ifeyinwa Obiorah; Surojeet Sengupta; Ramona Curpan; V Craig Jordan
Journal:  Mol Pharmacol       Date:  2014-03-07       Impact factor: 4.436

6.  High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy.

Authors:  P E Lønning; P D Taylor; G Anker; J Iddon; L Wie; L M Jørgensen; O Mella; A Howell
Journal:  Breast Cancer Res Treat       Date:  2001-05       Impact factor: 4.872

7.  Differences in the rate of oestrogen-induced apoptosis in breast cancer by oestradiol and the triphenylethylene bisphenol.

Authors:  I E Obiorah; V C Jordan
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

8.  Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells.

Authors:  S Sengupta; I Obiorah; P Y Maximov; R Curpan; V C Jordan
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

9.  The 38th David A. Karnofsky lecture: the paradoxical actions of estrogen in breast cancer--survival or death?

Authors:  V Craig Jordan
Journal:  J Clin Oncol       Date:  2008-06-02       Impact factor: 44.544

10.  Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.

Authors:  M H Jeng; M A Shupnik; T P Bender; E H Westin; D Bandyopadhyay; R Kumar; S Masamura; R J Santen
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736
View more
  9 in total

Review 1.  Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation.

Authors:  S Hüser; S Guth; H G Joost; S T Soukup; J Köhrle; L Kreienbrock; P Diel; D W Lachenmeier; G Eisenbrand; G Vollmer; U Nöthlings; D Marko; A Mally; T Grune; L Lehmann; P Steinberg; S E Kulling
Journal:  Arch Toxicol       Date:  2018-08-21       Impact factor: 5.153

2.  The modulation of estrogen-induced apoptosis as an interpretation of the women's health initiative trials.

Authors:  Balkees Abderrahman; V Craig Jordan
Journal:  Expert Rev Endocrinol Metab       Date:  2015-12-23

Review 3.  The molecular, cellular and clinical consequences of targeting the estrogen receptor following estrogen deprivation therapy.

Authors:  Ping Fan; Philipp Y Maximov; Ramona F Curpan; Balkees Abderrahman; V Craig Jordan
Journal:  Mol Cell Endocrinol       Date:  2015-06-05       Impact factor: 4.102

Review 4.  Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer.

Authors:  Ping Fan; V Craig Jordan
Journal:  Target Oncol       Date:  2022-03-15       Impact factor: 4.864

5.  Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer.

Authors:  Xingyi Guo; Qiuyin Cai; Pingping Bao; Jie Wu; Wanqing Wen; Fei Ye; Wei Zheng; Ying Zheng; Xiao-Ou Shu
Journal:  Cancer       Date:  2016-05-16       Impact factor: 6.860

Review 6.  Mind the gap-deficits in our knowledge of aspects impacting the bioavailability of phytochemicals and their metabolites--a position paper focusing on carotenoids and polyphenols.

Authors:  Torsten Bohn; Gordon J McDougall; Amparo Alegría; Marie Alminger; Eva Arrigoni; Anna-Marja Aura; Catarina Brito; Antonio Cilla; Sedef N El; Sibel Karakaya; Marie C Martínez-Cuesta; Claudia N Santos
Journal:  Mol Nutr Food Res       Date:  2015-06-03       Impact factor: 5.914

7.  An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.

Authors:  Xiaotong Zhang; Gengyi Zou; Xiyang Li; Lun Wang; Tianyu Xie; Jin Zhao; Longlong Wang; Shunchang Jiao; Rong Xiang; Haoyu Ye; Yi Shi
Journal:  Cancer Biol Med       Date:  2020-08-15       Impact factor: 4.248

Review 8.  Genistein: A Potent Anti-Breast Cancer Agent.

Authors:  Smitha S Bhat; Shashanka K Prasad; Chandan Shivamallu; Kollur Shiva Prasad; Asad Syed; Pruthvish Reddy; Charley A Cull; Raghavendra G Amachawadi
Journal:  Curr Issues Mol Biol       Date:  2021-10-10       Impact factor: 2.976

9.  Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Authors:  Cecilie Kyrø; Raul Zamora-Ros; Augustin Scalbert; Anne Tjønneland; Laure Dossus; Christoffer Johansen; Pernille Envold Bidstrup; Elisabete Weiderpass; Jane Christensen; Heather Ward; Dagfinn Aune; Elio Riboli; Mathilde His; Françoise Clavel-Chapelon; Laura Baglietto; Verena Katzke; Tilman Kühn; Heiner Boeing; Anna Floegel; Kim Overvad; Cristina Lasheras; Noémie Travier; Maria-José Sánchez; Pilar Amiano; Maria-Dolores Chirlaque; Eva Ardanaz; Kay-Tee Khaw; Nick Wareham; Aurora Perez-Cornago; Antonia Trichopoulou; Pagona Lagiou; Effie Vasilopoulou; Giovanna Masala; Sara Grioni; Franco Berrino; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H Peeters; Carla van Gils; Signe Borgquist; Salma Butt; Anne Zeleniuch-Jacquotte; Malin Sund; Anette Hjartåker; Guri Skeie; Anja Olsen; Isabelle Romieu
Journal:  Breast Cancer Res Treat       Date:  2015-11-03       Impact factor: 4.872
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.